Ellen Relkin, attorney and co-lead counsel in the New Jersey Ozempic lawsuits on NAION vision loss, shares exclusive insight and guidelines for anyone taking a GLP-1 medication.
Donald Walton has asked local elected officials in the Town of Edinburg to erect cautionary signage for drivers in his ...
NewsNation on MSN
Wegovy user suffers permanent vision loss after taking popular GLP-1 weight-loss drug
Jason Horek said he took Wegovy to lose a few pounds. Months later, he was diagnosed with a rare eye condition that left him with permanent vision loss in one eye, a condition researchers are studying ...
Even though studies have linked GLP-1s to development of nonarteritic anterior ischemic neuropathy, the risk is not great enough to warrant stopping the medication, according to a speaker at Academy ...
British research involving almost 1,000 patients found that about a fifth encountered treatments they deemed fraudulent. The majority of patients said they'd skipped these types of "treatments," ...
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, ...
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed treatment of diabetes and obesity, with positive effects reported on cardiovascular events, blood pressure, cholesterol levels and ...
Health headlines for Wednesday, Sept. 23 include GLP-1 vision loss lawsuits, a new Alzheimer's brain map and ibogaine under scrutiny. (Adobe Stock Photo) ...
She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. “It’s been very challenging,” she says. Here’s what doctors say about the risk. Hundreds of ...
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...
More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results